Susceptibility to Chronic Post-Traumatic Extremity Pain
1 other identifier
observational
250
1 country
2
Brief Summary
The association between the COMT haplotypes and the presence or absence of CPSP or CRPS will be assessed stratifying the patients based on the individual categories of trauma or elective surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2008
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 2, 2008
CompletedFirst Posted
Study publicly available on registry
May 6, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedSeptember 4, 2020
September 1, 2020
4.3 years
May 2, 2008
September 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neuropathic Pain Scale
6 months
Secondary Outcomes (2)
EQ-5D
6 months
Numeric Rating Scale for pain
6 months
Study Arms (3)
C
APS
B
HPS
A
LPS
Eligibility Criteria
Patients undergoing shoulder surgery
You may qualify if:
- Provide written Informed Consent prior to participation in the study
- Be at lease 18, but not more than 80 years of age
- Have the ability to read and understand the study procedures and the use of the pain scales and have the ability to communicate meaningfully with the Study Investigator and staff.
- Be free of other physical, mental, or medical conditions, which, in the opinion of the Investigator, makes Study participation inadvisable
- Is scheduled to undergo open or arthroscopic shoulder surgery
- If the subject is a female of childbearing potential, have a negative pregnancy test on the day of surgery.
You may not qualify if:
- \- Has significant medical disease(s), laboratory abnormalities or conditions(s) that in the Investigator's judgment could compromise the Subject's welfare, ability to communicate with the Study staff, complete Study activities, or would otherwise contraindicate Study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corewell Health Eastlead
- Beaumont Foundation of Americacollaborator
- Oakland Universitycollaborator
Study Sites (2)
William Beaumont Hospitals
Royal Oak, Michigan, 48073, United States
William Beaumont Hospital
Troy, Michigan, 48085, United States
Biospecimen
Whole blood serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Craig Hartrick, MD
Corewell Health East
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2008
First Posted
May 6, 2008
Study Start
April 1, 2008
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
September 4, 2020
Record last verified: 2020-09